This is a Validated Antibody Database (VAD) review about Rhesus mon.. IL2RA, based on 44 published articles (read how Labome selects the articles), using IL2RA antibody in all methods. It is aimed to help Labome visitors find the most suited IL2RA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IL2RA synonym: IL-2RA; interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA; interleukin 2 receptor, alpha; interleukin-2 receptor alpha chain

BioLegend
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s10d
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig s10d). Nature (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1e
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1e). PLoS Pathog (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1a). Bone Marrow Transplant (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1b
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1b). J Exp Med (2018) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1
BioLegend IL2RA antibody (BioLegend, M-A251) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 4a
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 4a). Int J Infect Dis (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 7a
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 7a). Nat Immunol (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 3d). Antimicrob Agents Chemother (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3g
In order to study the involvement of interleukin-8 on T lymphocytes growth and function, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 3g). Int Immunopharmacol (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IL2RA antibody (BioLegend, 302610) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3c
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 3c). Oncotarget (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IL2RA antibody (BioLegend, 356130) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, BioLegend IL2RA antibody (Biolegend, 302612) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 6f
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 6f). J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 7a
In order to determine which cells express CD83, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 7a). J Immunol (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend IL2RA antibody (Biolegend, M-A251) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; Rhesus monkey; loading ...; fig 2
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BioLegend IL2RA antibody (BioLegend, 302630) was used in flow cytometry on Rhesus monkey samples (fig 2). Science (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s7
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend IL2RA antibody (Biolegend, 302630) was used in flow cytometry on human samples (fig s7). Cell (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s2
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig s2). PLoS Pathog (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; 1:100; fig 3f
In order to investigate the impact of a cancer-specific MUC1 glycoform, BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples at 1:100 (fig 3f). Nat Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 4a
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 4a). J Exp Med (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; mouse; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on mouse samples . Science (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; African green monkey; loading ...; fig s2
In order to discuss the use of flow cytometry to examine common marmosets, BioLegend IL2RA antibody (BioLegend, M-A251) was used in flow cytometry on African green monkey samples (fig s2). J Med Primatol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1b
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1b). Nat Immunol (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 5b
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend IL2RA antibody (BioLegend, M-A251) was used in flow cytometry on human samples (fig 5b). Am J Transplant (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 6b
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 6b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 8a
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 8a). PLoS Pathog (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s1
BioLegend IL2RA antibody (BioLegend, 302609) was used in flow cytometry on human samples (fig s1). Sci Rep (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3b
In order to demonstrate that TGF-beta induces the differentiation of human CXCL13-producing CD4 positive T cells from naive CD4 positive T cells, BioLegend IL2RA antibody (BioLegend, M-A251) was used in flow cytometry on human samples (fig 3b). Eur J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
In order to study factors that specify the Treg lineage, BioLegend IL2RA antibody (BioLegend, 302606) was used in flow cytometry on human samples (fig 1). elife (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 5a
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 5a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; tbl s1
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s1
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3a
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 3a). J Immunol Res (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1). J Autoimmun (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 4
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend IL2RA antibody (BioLegend, clone BC96) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (BC96)
BioLegend IL2RA antibody (Biolegend, 302606) was used . PLoS ONE (2014) ncbi
mouse monoclonal (M-A251)
BioLegend IL2RA antibody (Biolegend, M-A251) was used . PLoS ONE (2014) ncbi
mouse monoclonal (BC96)
BioLegend IL2RA antibody (Biolegend, 302606) was used . J Biol Chem (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
BioLegend IL2RA antibody (Biolegend, BC96) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BioLegend IL2RA antibody (BioLegend, BC96) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
Articles Reviewed
  1. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  2. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  3. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed publisher
  4. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed publisher
  5. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  6. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  7. Zemmour D, Zilionis R, Kiner E, Klein A, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. 2018;19:291-301 pubmed publisher
  8. Meng W, Tang A, Ye X, Gui X, Li L, Fan X, et al. Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody. Antimicrob Agents Chemother. 2018;62: pubmed publisher
  9. Meniailo M, Malashchenko V, Shmarov V, Gazatova N, Melashchenko O, Goncharov A, et al. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017;50:178-185 pubmed publisher
  10. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  11. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  12. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed publisher
  13. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  14. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  15. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  16. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  17. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  18. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  19. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  20. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed publisher
  21. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  22. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  23. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  24. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  25. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  26. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  27. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  28. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  29. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  30. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed publisher
  31. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed publisher
  32. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed publisher
  33. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  34. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  35. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed publisher
  36. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  37. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  38. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  39. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  40. Reichwald K, Jørgensen T, Skov S. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS ONE. 2014;9:e105627 pubmed publisher
  41. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  42. Han L, Yang J, Wang X, Wu Q, Yin S, Li Z, et al. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor ?t (ROR?t) in Th17 cells. J Biol Chem. 2014;289:25546-55 pubmed publisher
  43. Meira M, Sievers C, Hoffmann F, Rasenack M, Kuhle J, Derfuss T, et al. Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. J Immunol Res. 2014;2014:897249 pubmed publisher
  44. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher